CIK 0000921114 · Non-accelerated filer<br>Smaller reporting company
Armata Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ARMP
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 911549568
- Phone
- 310-665-2928
- Business address
- 5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
- Former names
- AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-13 | Morris Duane Alfred VP of Operations | Grant or award · Stock Options (Right to Buy) | +41,000 | 41,000 | ||
| 2022-04-13 | Varnum Brian President and CEO | Grant or award · Stock Options (Right to Buy) | +240,000 | 240,000 | ||
| 2022-03-31 | Innoviva, Inc. Director | Purchase | +5,385,208 | $5.00 | $26.9M | 16,365,969 |
| 2022-03-31 | Innoviva, Inc. Director | Purchase · Warrants to Purchase Common Stock | +0 | $5.00 | $0 | 2,692,604 |
| 2022-02-09 | Innoviva, Inc. Director | Purchase | +3,614,792 | $5.00 | $18.1M | 10,980,761 |
| 2022-02-09 | Innoviva, Inc. Director | Purchase · Warrants to Purchase Common Stock | +1,807,396 | $5.00 | $9.0M | 1,807,396 |
| 2021-10-29 | Innoviva, Inc. Director | Purchase | +1,212,122 | $3.30 | $4.0M | 7,365,969 |
| 2021-08-02 | Varnum Brian CEO | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2021-06-07 | Schlesinger Sarah J. Director | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2021-06-07 | Peterson Todd C. Director | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2021-06-07 | PATTI JOSEPH M Director | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2021-06-07 | Kramer Robin Director | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2021-06-07 | Odysseas Kostas D Director | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2021-04-01 | Haimovitz Jules Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2021-03-25 | Varnum Brian President and CDO | Grant or award · Stock Option (Right to Buy) | +112,000 | 112,000 | ||
| 2021-03-25 | Patrick Todd Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +112,000 | 112,000 | ||
| 2021-03-25 | Morris Duane Alfred VP of Operations | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2021-03-25 | Martin Steven Robert Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +56,000 | 56,000 | ||
| 2021-03-17 | Innoviva, Inc. Director | Purchase | +4,285,935 | $3.25 | $13.9M | 6,153,847 |
| 2021-03-17 | Innoviva, Inc. Director | Purchase · Warrants to Purchase Common Stock | +4,285,935 | $3.25 | $13.9M | 6,153,847 |
Page 4 of 7 · 122 trades